Diagnos Laboratorium Utama Tbk. vs Bank China Construction Bank Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Bank China Construction Bank Indonesia Tbk. trades at Rp68 (market cap 2.52T, 1.21M 24h volume). The key difference: Bank China Construction Bank Indonesia Tbk. is far larger — about 8.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank China Construction Bank Indonesia Tbk. is more actively traded (1.21M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | MCOR | |
|---|---|---|
Market Cap | 310.75B | 2.52T |
Volume | 963.6K | 1.21M |
Lot | 9.64K | 12.07K |
Turnover | 217.67M | 81.26M |
Average Price | 225.89 | 67.32 |
Value | 217.67M | 81.26M |
Indicative Equilibrium Price | 226 | 67 |
Indicative Equilibrium Volume | 1K | 1.8K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Bank Multicor (Bank) was established under its original name of PT Multinational Finance Corporation base on notarial deed No.4 of Mr Bagijo, S.H, dated on Apr 2, 1974. The Company’s articles of association has been amended several times, most recently by notarial deed No. 143 of Eliwati Tjitra, S.H., dated Mar 21, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering. The Bank's name was changed to PT Bank Windu Kentjana International Tbk.
Read more on MCOR →